Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · IEX Real-Time Price · USD
44.53
+1.83 (4.29%)
At close: Jul 26, 2024, 4:00 PM
44.50
-0.03 (-0.07%)
After-hours: Jul 26, 2024, 7:34 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $4.36 billion as of July 26, 2024. Its market cap has increased by 542.69% in one year.
Market Cap
4.36B
Enterprise Value
3.93B
1-Year Change
542.69%
Ranking
Category
Stock Price
$44.53
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $4.36B, an increase of 451.11%. That is a compound annual growth rate of 55.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 3.73B | 357.09% |
| Dec 29, 2023 | 816.30M | 35.10% |
| Dec 30, 2022 | 604.20M | -1.39% |
| Dec 31, 2021 | 612.70M | -35.80% |
| Dec 31, 2020 | 954.30M | 20.66% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.70B |
| RadNet | 4.70B |
| Haemonetics | 4.66B |
| Apellis Pharmaceuticals | 4.54B |
| Alkermes | 4.49B |
| Avidity Biosciences | 4.27B |
| Crinetics Pharmaceuticals | 4.21B |
| Integer Holdings | 4.17B |